After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, TAK falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Takeda Pharmaceutical Co ADR is $44.79B. A total of 0.98 million shares were traded on the day, compared to an average of 2.16M shares.
In the most recent transaction, Giles Richard Platford bought 19,073 shares of TAK for 14.94 per share on Aug 23 ’24. In a previous transaction on Jan 24 ’24, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares at 8.10 per share. TAK shares that 10% Owner owns now total 3,755,583.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Takeda Pharmaceutical Co ADR pays an annual dividend of $0.29, resulting in a dividend yield of 2.07%, and it has a price to earnings (P/E) ratio of 46.30.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, TAK has a high of $15.08 and a low of $12.57.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. TAK’s latest balance sheet shows that the firm has $875.00B in Cash & Short Term Investments as of fiscal 2022. There were $4.35T in debt and $2.15T in liabilities at the time. Its Book Value Per Share was $15.45, while its Total Shareholder’s Equity was $5.68T.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TAK is Buy with a score of 4.50.
